India  

"Serum Institute"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being..

Credit: HT Digital Content     Duration: 01:19Published
COVID-19: No shortage of oxygen in country, says Health Ministry [Video]

COVID-19: No shortage of oxygen in country, says Health Ministry

Union Health Ministry Secretary, Rajesh Bhushan on September 15 denied the shortage of oxygen in the country and said there is sufficient oxygen for the patients. He said, "Today's capacity for..

Credit: ANI     Duration: 02:54Published
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine [Video]

Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India. He said, Cadila and Bharat Biotech have completed..

Credit: ANI     Duration: 01:21Published
Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning [Video]

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning

From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the..

Credit: HT Digital Content     Duration: 02:18Published
Paresh Rawal appointed chief of NSD by President Kovind | Oneindia News [Video]

Paresh Rawal appointed chief of NSD by President Kovind | Oneindia News

Serum Institute halts Covid vaccine trials in India; Reliance to offer $20 bn stake in retail arm to Amazon; Veteran RJD leader Raghuvansh Prasad quits party; South actor Vishal compares Kangana to..

Credit: Oneindia     Duration: 02:48Published
India's drug firm Serum Institute gets notice after Oxford vaccine trial put on hold |Oneindia News [Video]

India's drug firm Serum Institute gets notice after Oxford vaccine trial put on hold |Oneindia News

The Serum Institute of India which is manufacturing the Oxford University's Covishield vaccine has been issued a showcause notice by the country's drug controller DGCI. Trials for the vaccine were..

Credit: Oneindia     Duration: 01:15Published
Astrazeneca claims Covid-19 vaccine trial pause may not be a setback [Video]

Astrazeneca claims Covid-19 vaccine trial pause may not be a setback

Hindustan Times' National Political Editor, Sunetra Choudhury brings you the top stories you need to know. Sunetra talks about the number of Covid-19 cases in India so far, rise of cases in Maharashtra..

Credit: HT Digital Content     Duration: 04:04Published
Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia [Video]

Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia

As the race for a COVID-19 vaccine rages on, Bangladesh's leading pharma company Beximco has announced it will be investing in Adar Poonawalla's Serum India Limited for development of the vaccine. The..

Credit: Oneindia     Duration: 01:08Published
Covid: Serum Institute begins human trials, 5 volunteers given first shot [Video]

Covid: Serum Institute begins human trials, 5 volunteers given first shot

The Phase II human clinical trial of the Oxford COVID-19 vaccine candidate, being manufactured by the city-based Serum Institute of India (SII), began at a medical college and hospital here on..

Credit: HT Digital Content     Duration: 02:01Published
Second national sero-survey to be completed in September first week: ICMR [Video]

Second national sero-survey to be completed in September first week: ICMR

Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication. Bhargava said,..

Credit: ANI     Duration: 01:49Published
Covid update: Serum Institute clarifies; SOPs for TV shoots; weekend lockdown [Video]

Covid update: Serum Institute clarifies; SOPs for TV shoots; weekend lockdown

From Serum Institute of India clarifying over availability of vaccine shots to the government announcing new SOPs for resuming film and TV shooting, here are the top updates on coronavirus. Serum..

Credit: HT Digital Content     Duration: 02:32Published
Covid vaccine: SII to manufacture 100 million doses for India & others | Oneindia News [Video]

Covid vaccine: SII to manufacture 100 million doses for India & others | Oneindia News

Serum Institute of India to manufacture 100 million vaccine doses at Rs 225 per dose to India & other countries; At least 15 dead in Kerala landslide, search operations underway; Rhea Chakraborty..

Credit: Oneindia     Duration: 02:06Published
Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR [Video]

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

At present country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava on Tuesday...

Credit: HT Digital Content     Duration: 06:42Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR [Video]

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3..

Credit: ANI     Duration: 02:24Published
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again [Video]

COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health..

Credit: ANI     Duration: 01:38Published

You Might Like


Serum Institute all set to begin phase 3 trials of Covid-19 vaccine


newKerala.com - Published Also reported by •Hindu

Phase 3 trial of Oxford vaccine from next week

The phase-III human clinical trial of the Covid-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune..
IndiaTimes - Published

30 COVID-19 vaccine candidates in pre-clinical and clinical stages: Health Ministry

The Pune-based Serum Institute would conduct the Phase 3 trial on 1,500 volunteers across 14 locations.
DNA - Published

COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan

Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year. The remarks come at a time when India is recording..
Mid-Day - Published

Covishield trial: After DCGI nod to Serum institute, trial sites wait for go-ahead to resume enrolment of volunteers


Indian Express - Published

Serum Institute gets nod for resumption of Oxford vax trials


newKerala.com - Published

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while..
Mid-Day - Published Also reported by •Zee NewsIndiaTimesDNA

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DNA - Published Also reported by •newKerala.com

No shortage of medical oxygen for COVID-19 patients: Health Ministry

The Health Ministry on Tuesday clarified that there is no dearth of medical oxygen in the country, in wake of reports about its scarcity, and in fact, there is a surplus of thousands of metric..
Mid-Day - Published

COVID-19: India did not have huge peak at all, says ICMR DG

Lauding the nation-wide lockdown, ICMR Director General Balram Bhargava on Tuesday said that the country distributed the Covid-19 curve in such a way that it did not have many deaths and did not..
Mid-Day - Published

COVID-19: India's role in production of vaccine critical in containing pandemic says Bill Gates

Billionaire philanthropist Bill Gates has said India's willingness to play a "big role" in manufacturing *COVID-19* vaccine and allow it to supply to other developing countries will be a critical part..
Mid-Day - Published

Serum Institute's big announcement on coronavirus vaccine, here's when you will get first dose of COVID-19 vaccine

The Serum Institute is working with 5 international companies to develop the coronavirus vaccine.
DNA - Published

For high-risk groups, government plans to fast-track vaccine

India has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3...
IndiaTimes - Published

Serum Institute to resume vaccine trials after DCGI nod


IndiaTimes - Published Also reported by •newKerala.com

Will resume Covid-19 vaccine trials after DCGI nod: Serum Institute


IndiaTimes - Published

Top news of the day: Chinese Army hands over five youth to India; drug regulator directs Serum Institute to suspend recruitment for COVID-19 vaccine trials, and more

The major news headlines of the day, and more.
Hindu - Published

DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials


newKerala.com - Published Also reported by •IndiaTimes

Oxford vaccine: DCGI directs Serum Institute of India to suspend recruitment for trials

SII has also been asked to increase the safety monitoring of the subjects who have already been vaccinated
Hindu - Published Also reported by •IndiaTimes

DCGI suspends Serum Institute`s phase 2, 3 clinical trials of AstraZeneca`s COVID-19 vaccine

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19..
Zee News - Published

Top news of the day: Serum Institute pauses COVID-19 vaccine trial; five Rafale jets formally inducted into IAF, and more

The major news headlines of the day, and more.
Hindu - Published

 Page 1  〉